Radcliffe Capital Management’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

Radcliffe Capital Management’s Portfolio AONCW Stock Details AONCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-125,000	Closed	-$19.4K	–	506
2023 Q2	$19.4K	Hold	125,000	–	–	﹤0.01%	339
2023 Q1	$8.95K	Hold	125,000	–	–	﹤0.01%	560
2022 Q4	$1.26M	Hold	125,000	–	–	0.04%	613
2022 Q3	$1.23M	Hold	125,000	–	–	0.03%	846
2022 Q2	$1.22M	Hold	125,000	–	–	0.03%	897
2022 Q1	$1.22M	Hold	125,000	–	–	0.03%	885
2021 Q4	$1.22M	Hold	125,000	–	–	0.03%	772
2021 Q3	$1.21M	Hold	125,000	–	–	0.04%	658
2021 Q2	$1.22M	Buy	+125,000	New	+$99.8K	0.04%	675

Other funds holding AONCW

SCM

Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

SBLIC

Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return

HCM

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

EFI

EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return

Radcliffe Capital Management's AONCW Position: Q3 2023 in Review

Radcliffe Capital Management sold out of American Oncology Network, Inc. Warrant (AONCW) in Q3 2023, closing a stake of 125,000 shares — an estimated $19.4K sold.

Radcliffe Capital Management first reported a position in AONCW in Q2 2021 and held it in 9 quarters. The position peaked at $1.26M in Q4 2022. 34 funds tracked by Wall St. Rank hold AONCW as of Q3 2023.

Radcliffe Capital Management reported no remaining American Oncology Network, Inc. Warrant position as of Q3 2023 after selling out during the quarter.
Radcliffe Capital Management sold 125,000 American Oncology Network, Inc. Warrant shares in Q3 2023, an estimated $19.4K.
Radcliffe Capital Management first reported a position in American Oncology Network, Inc. Warrant in Q2 2021 and held it in 9 quarters.
Radcliffe Capital Management's American Oncology Network, Inc. Warrant position peaked at $1.26M in Q4 2022.
34 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q3 2023.

Based on Radcliffe Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.